Phenylketonuria Trial, Recruiting NCT07526909 Sponsor: Hacettepe University Condition: Phenylketonuria
Back to Phenylketonuria

Phenylketonuria Trial, Recruiting

NCT07526909
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older
  • You have been diagnosed with classic PKU (phenylketonuria)
  • You are not currently active in sports
  • You do not have any other existing health conditions
  • You do not currently have any infection
  • Your BMI (a measure of body weight relative to height) has been between 20 and 28 within the last 3 months
  • You are willing to eat specific test meals and give blood samples to measure amino acid levels as part of the study
  • You are willing to take part in this research

Who may not be able to join:

  • You have a long-term (chronic) illness alongside your PKU, such as a hormonal or glandular condition
  • You have an intellectual disability related to PKU, or have been assessed as being unable to carry out certain tasks based on a psychological and movement assessment (confirm with trial site)
  • You have recently lost weight, been admitted to hospital, had an infection, or been diagnosed with a new illness
  • You are taking any medications or using alcohol that can affect how your body processes protein or energy (for example, steroid-type medicines)
  • You are pregnant
  • You are a smoker
  • You have done intense exercise or played sport in the 24 hours before the test meals are given
  • You are currently on your menstrual period (for female participants)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: SERAP SIVRI, Professor, MD, Hacettepe University

Phone: +905543528779

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 October 2025
Est. completion
31 May 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Change in Plasma Phenylalanine Levels

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov